These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15478526)

  • 1. Daily vs twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following acute spinal cord injury.
    Hebbeler SL; Marciniak CM; Crandall S; Chen D; Nussbaum S; Mendelewski S
    J Spinal Cord Med; 2004; 27(3):236-40. PubMed ID: 15478526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxaparin versus tinzaparin for venous thromboembolic prophylaxis during rehabilitation after acute spinal cord injury: a retrospective cohort study comparing safety and efficacy.
    Marciniak CM; Kaplan J; Welty L; Chen D
    PM R; 2012 Jan; 4(1):11-7. PubMed ID: 22269449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.
    Slavik RS; Chan E; Gorman SK; de Lemos J; Chittock D; Simons RK; Wing PC; Ho SG
    J Trauma; 2007 May; 62(5):1075-81; discussion 1081. PubMed ID: 17495705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
    Merli G; Spiro TE; Olsson CG; Abildgaard U; Davidson BL; Eldor A; Elias D; Grigg A; Musset D; Rodgers GM; Trowbridge AA; Yusen RD; Zawilska K;
    Ann Intern Med; 2001 Feb; 134(3):191-202. PubMed ID: 11177331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.
    Heit JA; Colwell CW; Francis CW; Ginsberg JS; Berkowitz SD; Whipple J; Peters G;
    Arch Intern Med; 2001 Oct; 161(18):2215-21. PubMed ID: 11575978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
    Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; Segers AE; Cariou R; Leeuwenkamp O; Lensing AW;
    Ann Intern Med; 2004 Jun; 140(11):867-73. PubMed ID: 15172900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of thromboembolism in spinal injuries--results of enoxaparin used in 276 patients.
    Deep K; Jigajinni MV; McLean AN; Fraser MH
    Spinal Cord; 2001 Feb; 39(2):88-91. PubMed ID: 11402364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.
    Chong BH; Brighton TA; Baker RI; Thurlow P; Lee CH;
    J Thromb Thrombolysis; 2005 Jun; 19(3):173-81. PubMed ID: 16082604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
    Bauer KA; Eriksson BI; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1305-10. PubMed ID: 11794149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost comparison of tinzaparin versus enoxaparin as deep venous thrombosis prophylaxis in spinal cord injury: preliminary data.
    Wade WE; Spruill WJ
    Blood Coagul Fibrinolysis; 2001 Dec; 12(8):619-25. PubMed ID: 11734661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-Daily Versus Twice-Daily Enoxaparin for the Treatment of Acute Venous Thromboembolism in Cancer Patients.
    Fuller K; Malecki S; Anselmo L; Borrego ME; Jakeman B; Burnett A
    Ann Pharmacother; 2018 Mar; 52(3):257-262. PubMed ID: 29025276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
    Spiro TE; Johnson GJ; Christie MJ; Lyons RM; MacFarlane DE; Blasier RB; Tremaine MD
    Ann Intern Med; 1994 Jul; 121(2):81-9. PubMed ID: 8017740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
    Eriksson BI; Bauer KA; Lassen MR; Turpie AG;
    N Engl J Med; 2001 Nov; 345(18):1298-304. PubMed ID: 11794148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of venous thromboembolism in the rehabilitation phase after spinal cord injury: prophylaxis with low-dose heparin or enoxaparin.
    Spinal Cord Injury Thromboprophylaxis Investigators
    J Trauma; 2003 Jun; 54(6):1111-5. PubMed ID: 12813331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients.
    Arnold JD; Dart BW; Barker DE; Maxwell RA; Burkholder HC; Mejia VA; Smith PW; Longley JM
    Am Surg; 2010 Jun; 76(6):563-70. PubMed ID: 20583509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dalteparin and enoxaparin for deep venous thrombosis prophylaxis in patients with spinal cord injury.
    Chiou-Tan FY; Garza H; Chan KT; Parsons KC; Donovan WH; Robertson CS; Holmes SA; Graves DE; Rintala DH
    Am J Phys Med Rehabil; 2003 Sep; 82(9):678-85. PubMed ID: 12960909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
    Fisher WD; Eriksson BI; Bauer KA; Borris L; Dahl OE; Gent M; Haas S; Homering M; Huisman MV; Kakkar AK; Kälebo P; Kwong LM; Misselwitz F; Turpie AG
    Thromb Haemost; 2007 Jun; 97(6):931-7. PubMed ID: 17549294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.